Ingevity (NGVT) | Financial Analysis & Statements
Ingevity Corporation Mid-cap Basic Materials
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
255.1M
Gross Profit
87.8M
34.42%
Operating Income
38.8M
15.21%
Net Income
-84.6M
-33.16%
EPS (Diluted)
$-2.37
Balance Sheet Metrics
Total Assets
1.7B
Total Liabilities
1.6B
Shareholders Equity
29.7M
Debt to Equity
54.59
Cash Flow Metrics
Operating Cash Flow
-31.2M
Free Cash Flow
73.5M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Ingevity Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.2B | 1.4B | 1.7B | 1.7B | 1.4B |
| Cost of Goods Sold | 706.1M | 951.7M | 1.2B | 1.1B | 878.7M |
| Gross Profit | 461.5M | 454.7M | 471.9M | 570.1M | 512.8M |
| Gross Margin % | 39.5% | 32.3% | 27.9% | 34.2% | 36.9% |
| Operating Expenses | |||||
| Research & Development | 28.4M | 28.1M | 31.8M | 30.3M | 26.3M |
| Selling, General & Administrative | 171.2M | 166.7M | 183.7M | 198.8M | 179.3M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 199.6M | 194.8M | 215.5M | 229.1M | 205.6M |
| Operating Income | 261.9M | 259.9M | 256.4M | 341.0M | 307.2M |
| Operating Margin % | 22.4% | 18.5% | 15.2% | 20.4% | 22.1% |
| Non-Operating Items | |||||
| Interest Income | 4.4M | 6.9M | 6.3M | 5.8M | 4.0M |
| Interest Expense | 77.1M | 97.8M | 93.3M | 61.8M | 51.7M |
| Other Non-Operating Income | -330.1M | -704.6M | -179.5M | -15.4M | -96.7M |
| Pre-tax Income | -142.1M | -535.6M | -10.1M | 269.6M | 162.8M |
| Income Tax | 8.2M | -105.3M | -4.7M | 58.0M | 44.7M |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 21.5% | 27.5% |
| Net Income | -167.1M | -430.3M | -5.4M | 211.6M | 118.1M |
| Net Margin % | -14.3% | -30.6% | -0.3% | 12.7% | 8.5% |
| Key Metrics | |||||
| EBITDA | 345.9M | 355.8M | 360.9M | 445.8M | 412.6M |
| EPS (Basic) | - | $-11.85 | $-0.15 | $5.54 | $2.97 |
| EPS (Diluted) | - | $-11.85 | $-0.15 | $5.50 | $2.95 |
| Basic Shares Outstanding | - | 36300000 | 36496000 | 38200000 | 39800000 |
| Diluted Shares Outstanding | - | 36300000 | 36496000 | 38200000 | 39800000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Ingevity Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 78.1M | 68.0M | 95.9M | 76.7M | 275.4M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 127.2M | 141.0M | 182.0M | 224.8M | 161.7M |
| Inventory | 186.0M | 226.8M | 308.8M | 335.0M | 241.2M |
| Other Current Assets | 6.7M | 13.9M | 32.3M | 11.9M | 6.5M |
| Total Current Assets | 454.2M | 493.2M | 658.6M | 683.3M | 724.9M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 65.1M | 100.3M | 107.8M | 97.4M | 87.9M |
| Goodwill | 224.1M | 674.3M | 1.4B | 1.5B | 1.3B |
| Intangible Assets | 215.5M | 323.9M | 385.3M | 455.8M | 378.7M |
| Long-term Investments | 0 | - | - | 0 | 2.0M |
| Other Non-Current Assets | 256.4M | 233.1M | 123.4M | 113.9M | 114.0M |
| Total Non-Current Assets | 1.2B | 1.5B | 2.0B | 2.1B | 1.7B |
| Total Assets | 1.7B | 2.0B | 2.6B | 2.7B | 2.5B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 92.0M | 94.5M | 158.4M | 174.8M | 125.8M |
| Short-term Debt | 58.9M | 78.2M | 103.1M | 17.4M | 37.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 4.1M | 200.0K | 1.4M | 2.1M | 600.0K |
| Total Current Liabilities | 341.3M | 264.1M | 362.9M | 303.5M | 268.9M |
| Non-Current Liabilities | |||||
| Long-term Debt | 1.2B | 1.4B | 1.4B | 1.5B | 1.3B |
| Deferred Tax Liabilities | 55.1M | 56.2M | 70.9M | 106.5M | 114.6M |
| Other Non-Current Liabilities | 10.5M | 7.7M | 6.8M | 7.0M | 7.7M |
| Total Non-Current Liabilities | 1.3B | 1.6B | 1.6B | 1.7B | 1.5B |
| Total Liabilities | 1.6B | 1.8B | 2.0B | 2.0B | 1.8B |
| Equity | |||||
| Common Stock | 400.0K | 400.0K | 400.0K | 400.0K | 400.0K |
| Retained Earnings | 404.9M | 572.0M | 1.0B | 1.0B | 796.1M |
| Treasury Stock | 571.8M | 512.6M | 509.5M | 416.0M | 272.1M |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 29.7M | 195.2M | 631.4M | 698.3M | 673.8M |
| Key Metrics | |||||
| Total Debt | 1.2B | 1.5B | 1.5B | 1.5B | 1.3B |
| Working Capital | 112.9M | 229.1M | 295.7M | 379.8M | 456.0M |
Balance Sheet Composition
Ingevity Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -167.1M | -430.3M | -5.4M | 211.6M | 118.1M |
| Depreciation & Amortization | 106.4M | 108.3M | 122.8M | 108.8M | 109.9M |
| Stock-Based Compensation | 18.3M | 11.9M | 10.6M | 16.1M | 12.3M |
| Working Capital Changes | 28.6M | -14.9M | -45.5M | -62.8M | 8.5M |
| Operating Cash Flow | 13.4M | -230.7M | 193.4M | 294.1M | 265.0M |
| Investing Activities | |||||
| Capital Expenditures | - | - | - | - | - |
| Acquisitions | - | 0 | 0 | -344.5M | 0 |
| Investment Purchases | -16.4M | -300.0K | -2.4M | -77.4M | -35.3M |
| Investment Sales | 13.0M | 0 | 31.5M | 14.7M | 0 |
| Investing Cash Flow | 200.0K | -1.9M | 32.5M | -409.4M | -34.8M |
| Financing Activities | |||||
| Share Repurchases | -56.3M | 0 | -92.1M | -145.2M | -109.4M |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 291.3M | 404.5M | 376.3M | 1.2B | 0 |
| Debt Repayment | -483.6M | -470.6M | -382.9M | -964.8M | -25.3M |
| Financing Cash Flow | -252.3M | -69.2M | -103.9M | 44.9M | -139.0M |
| Free Cash Flow | 273.5M | 51.0M | 95.3M | 170.9M | 189.5M |
| Net Change in Cash | -238.7M | -301.8M | 122.0M | -70.4M | 91.2M |
Cash Flow Trend
Ingevity Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
12.96
Forward P/E
12.62
Price to Book
89.27
Price to Sales
2.26
PEG Ratio
-0.02
Profitability Ratios
Profit Margin
-14.31%
Operating Margin
15.21%
Return on Equity
-133.66%
Return on Assets
8.91%
Financial Health
Current Ratio
1.33
Debt to Equity
4,184.18
Beta
1.28
Per Share Data
EPS (TTM)
$-4.15
Book Value per Share
$0.84
Revenue per Share
$32.24
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| NGVT | 2.7B | 12.96 | 89.27 | -133.66% | -14.31% | 4,184.18 |
| Linde plc | 236.5B | 34.73 | 6.16 | 17.82% | 20.30% | 70.63 |
| Sherwin-Williams | 83.7B | 32.88 | 18.09 | 59.39% | 10.90% | 306.06 |
| Element Solutions | 9.3B | 48.25 | 3.46 | 7.51% | 7.48% | 64.06 |
| Eastman Chemical | 8.2B | 17.58 | 1.38 | 7.99% | 5.42% | 84.41 |
| Arcadium Lithium plc | 6.3B | 64.89 | 1.00 | 2.78% | 10.24% | 14.03 |
Financial data is updated regularly. All figures are in the company's reporting currency.






